Management of heart failure among very old persons living in long-term care: Has the voice of trials spread?

American Heart Journal

Volumn 139, Issue 1 I, 2000, Pages 85-93

  Gambassi, Giovanni ^a,b   Forman, Daniel E ^c   Lapane, Kate L ^b   Mor, Vincent ^b   Sgadari, Antonio ^a   Lipsitz, Lewis A ^d   Bernabei, Roberto ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b BROWN UNIVERSITY   (United States)

^c MIRIAM HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

AGE; AGED; ARTICLE; CLINICAL FEATURE; COGNITION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; GERIATRIC PATIENT; HEALTH SERVICE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 0033985861     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90313-2     Document Type: Article

References (49)

1. Massie BM, Shah NB. Evolving trends in the epidemiology of heart failure: the rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-12.
2. National Heart, Lung, and Blood Institute. Congestive heart failure in the United States: a new epidemic. NIH Data Fact Sheet. Bethesda, Md: US Department of Health and Human Services; 1996:1-6.
3. Coats AJS. Is preventive medicine responsible for the increasing prevalence of heart failure. Lancet 1998;352 suppl I:39-41.
4. Walsh JT, Charlesworth A, Andrews R, Hawkins M, Cowley AJ. Relation of daily activity levels in patients with chronic heart failure to long-term prognosis. Am J Cardiol 1997;79:1364-9.
5. Jaagosild P, Dawson NV, Thomas C, Wenger NS, Tsevat J, Kanus WA, et al. Outcomes of acute exacerbation of severe congestive heart failure: quality of life, resource use, and survival. Arch Intern Med 1998;158:1081-9.
6. Krumholz HM, Parent EM, Tu N, Vaccarino V, Wang Y, Radford MJ, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 1997;157:99-104.
7. Massie BM. 15 years of heart-failure trials: what have we learned? Lancet 1998;352 suppl I:29-33.
8. Konstam MA, Dracup K, Baker DW, Bottorf MB, Brooks NH, Dacey RA, et al. Heart failure: evaluation and care of patients with left-ventricular systolic dysfunction. Rockville, Md: Agency for Health Care Policy and Research, 1994. Clinical practice guideline no. 11, AHCPR Publication no. 94-0612; 1994:1-22.
9. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation & Management of Heart Failure). Circulation 1995;92:2764-84.
10. The Task Force of the Working Group on Heart Failure of the European Society of Cardiology. The treatment of heart failure. Eur Heart J 1997;18:736-53.
11. Eccles M, Freemantle N, Mason J, for the North of England ACE inhibitor Guideline Development Group. North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure. BMJ 1998;316:1369-75.
12. Cleland JGF, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet 1998;352 suppl I:19-28.
13. Stafford RS, Saglam D, Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med 1997;157:2460-4.
14. The Large State Peer Review Organization Consortium. Heart failure treatment with angiotensin-converting enzyme inhibitors in hospitalized Medicare patients in 10 large states. Arch Intern Med 1997;157:1103-8.
15. Gattis WA, Larsen RL, Hasselblad V, Bart BA, O'Connor CM. Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J 1998;136:43-8.
16. Avorn J, Monette J, Lacour A, Bohn RL, Monane M, Mogun H, et al. Persistence of use of lipid-lowering medications. JAMA 1998;279:1458-62.
17. Bart BA, Gattis WA, Diem SJ, O'Connor CM. Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol 1997;79:1118-20.
18. Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol 1996;77:832-8.
19. O'Keeffe ST, Lye M. Heart failure in the elderly: the same syndrome as the clinical trials? In: McMurra JJV, Cleland JGF, editors. Heart failure in clinical practice. London: Martin Dunitz, 1996:47-71.
20. Parmley WW. Do we practice geriatric cardiology? J Am Coll Cardiol 1997;29:217-8.
21. Lindenfeld JA, Krause-Steinrauf H, Salerno J. Where are all the women with heart failure? J Am Coll Cardiol 1997;30:1417-9.
22. Krumholz H. Time to focus on the more typical heart-failure patients. Lancet 1998;352:3-4.
23. Bernabei R, Gambassi G, Mor V. The SAGE database: introducing functional outcomes in geriatric pharmaco-epidemiology. J Am Geriatr Soc 1998;46:250-2.
24. Gambassi G, Landi F, Peng L, Brostrup-Jensen C, Calore K, Hiris J, et al. Validity of diagnostic and drug data in standardized nursing home assessments: potential for geriatric pharmacoepidemiology. Med Care 1998;36:167-79.
25. Bernabei R, Gambassi G, Lapane KL, Sgadari A, Landi F, Gatsonis C, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. J Gerontol Med Sci 1999;54A:M25-M33.
26. Gambassi G, Sgadari A, Lapane K, Landi F, Mor V, Bernabei R. Measuring health outcomes for older people using the SAGE database. Can J Aging. In press.
27. Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, et al. Management of pain in elderly patients with cancer. JAMA 1998:279:1877-82.
28. Gambassi G, Lapane K, Sgadari A, Landi F, Carbonin PU, Hume AL, et al. Prevalence, clinical correlates and treatment of hypertension in elderly nursing home residents. Arch Intern Med 1998;158:2377-85.
29. Gambassi G, Lapane K, Sgadari A, Carbonin P, Gatsonis C, Lipsitz L, et al. Effects of ACE inhibitors and digoxin on health outcomes of very old patients with heart failure. Arch Intern Med. In press.
30. Pahor M, Guralnik JM, Gambassi G, Bernabei R, Carosella L, Carbonin P. The impact of age on risk of adverse drug reactions to digoxin. J Clin Epidemiol 1993;46:1305-14.
31. Forman DE, Coletta D, Kenny D, Kosowsky BD, Stoukides J, Rohrer M, et al. Clinical issues related to discontinuing digoxin therapy in elderly nursing home patients. Arch Intern Med 1991;151:2194-8.
32. Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors: how much should we worry? Arch Intern Med 1998;158:26-32.
33. Eichhorn EJ. Restoring function in failing hearts: the effects of beta-blockers. Am J Med 1998;104:163-9.
34. Arling ML. Management of heart failure in nursing facility residents and AMDA Heart Failure Guidelines. Nurs Home Med 1997;5:374-80.
35. Forman DE, Chander RB, Lapane KL, Shah P, Stoukides J. Evaluating use of angiotensin-converting enzyme inhibitors for elderly nursing home residents with chronic heart failure. J Am Geriatr Soc 1998;46:1550-4.
36. Forman DE, Gambassi G. Peculiar complexities in the management of our elderly cardiac patients. Am Coll Cardiol Rev 1999;2:93-4.
37. Forman DE, Lipsitz LA. Syncope in the elderly. Cardiol Clin 1997;15:295-311.
38. Lipsitz LA, Byrnes N, Hossain M, Douglas P, Waksmonski CA. Restrictive left ventricular filling patterns in very old patients with congestive heart failure: clinical correlates and prognostic significance. J Am Geriatr Soc 1996;44:634-7.
39. Aronow WS, Ahn C, Kronzon I. Normal left ventricular ejection fraction in older persons with congestive heart failure. Chest 1998;113:867-9.
40. Dauterman KW, Massie BM, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J 1998;135:S310-9.
41. Gambassi G, Carbonin PU, Bernabei R. Angiotensin converting enzyme inhibitors for elderly patients with congestive heart failure. Arch Intern Med 1998;158:97-8.
42. Zinn JS, Mor V, Castle N, Intrator O, Brannon D. Organizational and environmental factors associated with nursing home participation in managed care. Health Serv Res 1999;33:1753-7.
43. Chin MH, Goldman L. Factors contributing to the hospitalization of patients with congestive heart failure. Am J Public Health 1997;87:643-8.
44. Bennett SJ, Huster GA, Baker SL, Milgrom LB, Kirchgassner A, Birt J, et al. Characterization of the precipitants of hospitalization for heart failure decompensation. Am J Crit Care 1998;7:168-74.
45. Saketkhou BB, Conte FJ, Noris M, Tilkemeier P, Miller G, Forman DE, et al. Emergency department use of aspirin in patients with possible acute myocardial infarction. Ann Intern Med 1997:127:126-9.
46. Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med 1997;157:978-84.
47. Hamel MB, Phillips RS, Teno JM, Lynn J, Galanos AN, Davis RB, et al. Seriously ill hospitalized adults: do we spend less on older patients? J Am Geriatr Soc 1996;44:1043-8.
48. Hamel MB, Teno JM, Goldman L, Lynn J, Davis RB, Galanos AN, et al. Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized patients. Ann Intern Med 1999;130:116-25.
49. American Geriatrics Society Clinical Practice Committee. Heart failure: evaluation and treatment of patients with left ventricular systolic dysfunction. J Am Geriatr Soc 1998;46:525-9.